Robert Reiter, MD
Dr. Reiter is the Bing Professor of Urologic Oncology and Chief, Division of Urologic Oncology at UCLA. He is Principal Investigator on UCLA's Prostate Cancer SPORE. His research is focused on anatomical and molecular imaging of prostate cancer, as well as elucidation of the molecular mechanisms of prostate cancer progression.
Financial relationships
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:Pfizer
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:Lantheus
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:Point biopharma
-
Attribution:SelfType of financial relationship:Meeting Participant or Lecturer (Oncology)Ineligible company:Bayer
-
Attribution:SelfType of financial relationship:Meeting Participant or Lecturer (Specialty Not Specified)Ineligible company:Genomic Health
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Specialty Not Specified)Ineligible company:Janssen
-
Attribution:SelfType of financial relationship:Investment Interest (Specialty Not Specified)Ineligible company:ImaginAb Corporation